Mangalam Drugs & Organics Limited (MANGALAM.NS) NSE

Currency In INR

AD

Valuation

Market Cap429.76M
Enterprise Value1.48B
P/E Ratio-1.06
PEG Ratio0.01
Price/Sales Ratio0.2
Price/Book Ratio0.45
Enterprise/Revenue0.65
Enterprise/EBITDA-10.66

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.19
Operating Margin-0.14
AD

Management Effectiveness

Return On Assets-0.14
Return On Equity-0.34

Income Statement

Revenue2.32B
Revenue/Share146.76
Gross Profit232.46M
EBITDA-149.03M
Net Income-444M
Diluted EPS-28.05

Balance Sheet

Total Cash7.01M
Total Cash/Share0.44
Total Debt1.05B
Total Debt/Equity1.02
Current Ratio0.79
Book Value Per Share65.12

Price History

52-Week Change-62.86
52-Week High95
52-Week Low22.8
Moving Average 50 Days29.34
Moving Average 200 Days41.05

Statistics

Average Volume22,957
Shares Outstanding15.83M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD